Abstract:
Companies in the [U.S. drug] supply chain have until 2023 before the [Drug Supply Chain Security Act (DSCSA) ] requires tracing by the individual package serial number…  Until 2023, companies must trace drugs based only on their lot numbers.  This unique feature of the law sets up an inevitable transition in the industry from drug traceability based on the lot number to traceability based on the serial number. 

Please complete this brief form and your download will start immediately.